Liu W, Zhou W, Zhao P, Wu T, Gu H, Li Y, Zhong C, Bai H, Zhao N, Huang X (2025) PD-Like pathogenesis in Caenorhabditis elegans intestinally infected with Nocardia farcinica and the underlying molecular mechanisms
The peptide, typically administered as a nasal spray, has shown the most promise in humans for treating neurological conditions, particularly ischemic stroke, but there is no evidence for general cognitive enhancement
It invalidates the 28-day safety window entirely
Trial-Level Safety Signals to Know Pancreatitis Both compound classes (GLP-1 agonists and amylin analogs) have a small but documented pancreatitis signal across the GLP-1 trial database
The panel will review the evidence supporting the use of these peptides for specific indications, including ulcerative colitis, wound healing, obesity and migraines
Peptides on the FDAs restricted list are not allowed to be compounded